Drug Shortage Provisions In Draft PDUFA Bill Would Expedite Major Manufacturing Changes
Executive Summary
FDA would have 60 days to review major changes and could “deem” them compliant with current good manufacturing practices so long as the facility has a plan and resources to achieve full compliance and institutes quality control measures under draft legislation being developed by the House Energy and Commerce Committee.
You may also be interested in...
To Prevent Shortages, US FDA Wants Sponsor To Provide Notifications Of Demand Spike
Demand-related shortages are a relatively new problem, but the FDA maintains their tools can prevent or end them.
To Prevent Shortages, US FDA Wants Notices From Drug Firms On Spikes In Demand
Demand-related shortages are a relatively new problem, but FDA maintains its tools can prevent or end them.
To Prevent Shortages, US FDA Wants Sponsor To Provide Notifications Of Demand Spike
Demand-related shortages are a relatively new problem, but the FDA maintains their tools can prevent or end them.